Skip to content
10-Q

Quarterly Report

Yubo International Biotech Ltd YBGJ

0001640334-25-002083

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 170.42M sh
Shares Diluted Q3 2025 · Sep 30, 2025 147.87M sh
Shares Diluted Q3 2025 · Sep 30, 2025 129.27M sh
Shares Diluted Q3 2025 · Sep 30, 2024 119.82M sh
Shares Diluted Q3 2025 · Sep 30, 2024 119.82M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$714.05K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$405.02K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $10.93K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$1.66M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$3.42M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.56M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.72M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.56M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.83M
Current Assets Q3 2025 · Sep 30, 2025 $649.56K
Current Assets Q3 2025 · Dec 31, 2024 $682.75K
Total Assets Q3 2025 · Sep 30, 2025 $953.21K
Total Assets Q3 2025 · Dec 31, 2024 $1.53M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Net Income Q3 2025 · Sep 30, 2025 −$310.15K
Net Income Q3 2025 · Sep 30, 2025 −$902.29K
Net Income Q3 2025 · Sep 30, 2024 −$621.05K
Net Income Q3 2025 · Sep 30, 2024 −$1.63M
Operating Income Q3 2025 · Sep 30, 2025 −$310.13K
Operating Income Q3 2025 · Sep 30, 2025 −$902.23K
Operating Income Q3 2025 · Sep 30, 2024 −$532.76K
Operating Income Q3 2025 · Sep 30, 2024 −$1.41M
Gross Profit Q3 2025 · Sep 30, 2025 $0
Gross Profit Q3 2025 · Sep 30, 2025 $0
Gross Profit Q3 2025 · Sep 30, 2024 $0
Gross Profit Q3 2025 · Sep 30, 2024 $2.66K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $0
Cost Of Revenue Q3 2025 · Sep 30, 2025 $0
Cost Of Revenue Q3 2025 · Sep 30, 2024 $0
Cost Of Revenue Q3 2025 · Sep 30, 2024 $827
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $3.49K